Noticias y Actividades de CalciMedica
Ejecutivos
Ver el organigrama con sus 16 ejecutivos principales
Biografías más buscadas en CalciMedica
- Rachel Leheny, Director and Chief Executive Officer
- Evgeny Zaytsev, Director
- Robert Wilson, Chairman of the Board
Recientes movimientos de ejecutivos en CalciMedica
- Fred Middleton, Director, ha dejado la empresa (noticia publicada el 8 de julio de 2026).
- Evgeny Zaytsev, se ha incorporado a la empresa como Director (noticia publicada el 8 de julio de 2026).
- Fred Guerard, Director, ha dejado la empresa (noticia publicada el 8 de julio de 2026).
Crear su alerta
para seguir los movimientos de los ejecutivos en CalciMedica.
Biotecnología
CalciMedica tiene 2.429 competidores entre los que se incluyen Lonza (Suiza), Vertex Pharmaceuticals (Estados Unidos) y Eurofins (Luxemburgo).
Popular M&A news in Biotecnología
- Tempus has announced the acquisition of Personalis (publicado el 20 de julio de 2026).
- Eli Lilly has announced the acquisition of AtaiBeckley (publicado el 17 de julio de 2026).
- GSK ha Nuvalent adquirido (publicado el 17 de julio de 2026).
Otros contactos sugeridos en el sector Biotecnología
Noticias
Últimos comunicados de prensa de CalciMedica
- CalciMedica Announces Clinical Development of Auxora May Proceed Following FDA Review of KOURAGE Trial Interim Safety Data | CalciMedica, Inc.
- CalciMedica Reports First Quarter 2026 Financial Results and Provides Clinical & Corporate Updates | CalciMedica, Inc.
- CalciMedica Announces Private Placement Financing for Up to Approximately $49 Million to Advance Pulmonary Hypertension Program | CalciMedica, Inc.
- CalciMedica Reports 2025 Financial Results and Provides Clinical Updates | CalciMedica, Inc.
- CalciMedica Announces Discontinuation of Phase 2 KOURAGE Trial in AKI Following Independent Data Monitoring Committee Recommendation | CalciMedica, Inc.
- CalciMedica Reports Third Quarter 2025 Financial Results and Provides Clinical & Corporate Updates | CalciMedica, Inc.
- CalciMedica Announces Publication in JCI Insight of Preclinical Data Supporting CRAC Channel Inhibitor as a Potential Therapy for Pulmonary Arterial Hypertension | CalciMedica, Inc.
- CalciMedica Presents Data from Preclinical Study of Auxora™ in an Animal Model of AKI at ASN Kidney Week 2025 | CalciMedica, Inc.
- CalciMedica and Telperian Announce Collaboration to Integrate Innovative Artificial Intelligence Engine to Analysis of Clinical Trials of Auxora™ | CalciMedica, Inc.
- CalciMedica to Participate in the H.C. Wainwright 27th Annual Global Investment Conference | CalciMedica, Inc.
- View more press releases Close
Redes sociales sobre CalciMedica
- CalciMedica en Wikipedia, Google News y Yahoo Finance
- CalciMedica en LinkedIn, Twitter y YouTube
